Estrogen deficiency: In search of symptom control and sexuality.
Loprinzi
C L
CL
Barton
D
D
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy*; D016022:Case-Control Studies; D015986:Confounding Factors, Epidemiologic; D000075202:Contraindications; D020847:Estrogen Receptor Modulators / Q000009:adverse effects; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000172:deficiency*; D005260:Female; D005500:Follow-Up Studies; D020010:Heterosexuality; D006801:Humans; D008593:Menopause; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D012107:Research Design; D013629:Tamoxifen / Q000009:adverse effects
D018931:Antineoplastic Agents, Hormonal; D020847:Estrogen Receptor Modulators; D004967:Estrogens; D013629:Tamoxifen